Companies in #IgA Nephropathy (IgAN)
Found 1 company operating in this sector.
Vera Therapeutics is a late-stage clinical biopharmaceutical company developing treatments for serious immunological diseases. Its lead asset atacicept (a dual BAFF/APRIL inhibitor) received FDA approval in 2026 for IgA nephropathy (IgAN), establishing it as the first-in-class targeted therapy for this kidney disease.